ADMA Biologics, Inc.ADMANASDAQ
Loading
Operating Cash Flow Growth Under PressureDecelerating
Percentile Rank29
Studio
Year-over-Year Change

Year-over-year operating cash flow growth rate

Percentile
P29
Within normal range
vs 3Y Ago
-1.2x
Contraction
Streak
1 yr
Consecutive declineDecelerating
PeriodValue
2025-57.53%
20241248.55%
2023114.79%
202247.04%
2021-10.16%
2020-33.87%
2019-21.56%
2018-68.17%
2017-104.02%
2016-18.49%